Key claims

Strengths:

  • Effective in the treatment of manic and mixed states, either as monotherapy or add-on therapy to a mood stabilizer.
  • Rapid onset of antimanic effect which is independent of antipsychotic effects.
  • Broad spectrum – it controls mania in a variety of populations (psychotic/non-psychotic, and manic/mixed) and also reduces associated depressive symptoms.
  • Does not cause weight gain or QTc prolongation.
  • Superior to haloperidol in terms of rates of EPS.

Weaknesses:

  • Never studied in patients with bipolar depression.
  • Assoiciated with higher rates of EPS compared with other atypical antipsychotics.

Guidelines

Supporting data